The FDA has approved a generic version of liraglutide (Victoza) for type 2 diabetes in patients aged 10 and older,…
Browsing: Clinical Updates
A recent study has introduced an integrative risk score that effectively predicts the future onset of Crohn’s disease. This tool…
Pfizer has received FDA accelerated approval for BRAFTOVI (encorafenib) combined with cetuximab and mFOLFOX6 to treat metastatic colorectal cancer (mCRC)…
A new study published in Nature introduces NK2R agonists as a promising alternative to GLP-1 drugs for obesity and diabetes,…
The FDA has approved a generic version of liraglutide (Victoza) for managing blood sugar in type 2 diabetes patients aged…
The FDA has granted accelerated approval to a combination therapy led by encorafenib (Braftovi) for patients with BRAF V600E-mutant metastatic…
The field of gastroenterology witnessed transformative advancements in 2024, driven by groundbreaking clinical trials, updated practice guidelines, and innovative therapeutic…
Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. Originally released as a bonus episode…
International researchers have identified distinctive bacterial signatures in the gut microbiome that may lead to new, noninvasive diagnostics for inflammatory…
A clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has led to the FDA granting a Breakthrough Therapy Designation…